Close Menu

One a Week

WashU's David Dooling tells O'Reilly Radar's James Turner about all the genome sequencing work going on at his university, where scientists can now sequence a human genome with complete coverage in a week. "Now with 35 to 40 machines, we can generate lots of sequence on lots of different humans. And so that opens up a whole new line of analysis of comparative genomics where you're comparing human to human to human to human genomes," Dooling says. "This was an analysis that wasn't even feasible two years ago.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.